Open tender
Published
PR BHFT 0715 - Compounded mAbs - Cancer Therapies (replaces BHFT 0342)
2 suppliers have saved this notice.
Looks like a fit? Save this tender and qualify it in Stotles
Close date
2026-06-08
Description
Supply of Compounded Monoclonal Antibodies. Ranked framework split into 2 Lots as follows: Lot 1- High Volume Products - 5 molecules / all brands Pembrolizumab Rituximab Bevacizumab Daratumumab Nivolumab Lot 2 - Lower Volume Products - 14 molecules / all brands Pertuzumab/trastuzumab Brentuximab Cetuximab Atezolizumab Cemiplimab Avelumab Panitumumab Obinutuzumab Pertuzumab Trastuzumab Ipilimumab Isatuximab Polatuzumab
Qualify tenders faster with AI summaries - see key details in the Stotles app
Never miss a tender again
Get alerts, AI summaries and tools to qualify faster
Explore top buyers for public sector contracts
Discover open tenders, contract awards and upcoming contract expiries of thousands of public sector buyers below. Gain insights into their procurement activity, historical purchasing trends and more.
Sign up to the Stotles Tender Tracker for free
Find even more contracts with advanced search capability and AI powered relevance scoring.